Literature DB >> 30930334

Expounding on the essence of epigenetic and genetic abnormalities in blastic plasmacytoid dendritic cell neoplasms.

Lhara Lezama1, Robert S Ohgami2.   

Abstract

Entities:  

Mesh:

Year:  2019        PMID: 30930334      PMCID: PMC6442968          DOI: 10.3324/haematol.2018.211557

Source DB:  PubMed          Journal:  Haematologica        ISSN: 0390-6078            Impact factor:   9.941


× No keyword cloud information.
  20 in total

1.  CD123hi dendritic cell lymphoma: an unusual case of non-Hodgkin lymphoma.

Authors:  P Lúcio; A Parreira; A Orfao
Journal:  Ann Intern Med       Date:  1999-10-05       Impact factor: 25.391

2.  8q24/MYC rearrangement is a recurrent cytogenetic abnormality in blastic plasmacytoid dendritic cell neoplasms.

Authors:  Prajwal C Boddu; Sa A Wang; Naveen Pemmaraju; Zhenya Tang; Shimin Hu; Shaoying Li; Jie Xu; L Jeffrey Medeiros; Guilin Tang
Journal:  Leuk Res       Date:  2018-02-03       Impact factor: 3.156

3.  Recurrent 8q24 rearrangement in blastic plasmacytoid dendritic cell neoplasm: association with immunoblastoid cytomorphology, MYC expression, and drug response.

Authors:  Kana Sakamoto; Ryohei Katayama; Reimi Asaka; Seiji Sakata; Satoko Baba; Hideki Nakasone; Sumie Koike; Naoko Tsuyama; Akito Dobashi; Makoto Sasaki; Ryo Ichinohasama; Emi Takakuwa; Rie Yamazaki; Jun Takizawa; Takahiro Maeda; Miwako Narita; Koji Izutsu; Yoshinobu Kanda; Koichi Ohshima; Kengo Takeuchi
Journal:  Leukemia       Date:  2018-05-23       Impact factor: 11.528

4.  An analysis of blastic plasmacytoid dendritic cell neoplasm with translocations involving the MYC locus identifies t(6;8)(p21;q24) as a recurrent cytogenetic abnormality.

Authors:  Lhara Sumarriva Lezama; Karen M Chisholm; Eugene Carneal; Alexandra Nagy; Michael J Cascio; Jie Yan; Chung-Che Chang; Athena Cherry; Tracy I George; Robert S Ohgami
Journal:  Histopathology       Date:  2018-08-06       Impact factor: 5.087

5.  Molecular profiling of blastic plasmacytoid dendritic cell neoplasm reveals a unique pattern and suggests selective sensitivity to NF-kB pathway inhibition.

Authors:  M R Sapienza; F Fuligni; C Agostinelli; C Tripodo; S Righi; M A Laginestra; A Pileri; M Mancini; M Rossi; F Ricci; A Gazzola; F Melle; C Mannu; F Ulbar; M Arpinati; M Paulli; T Maeda; D Gibellini; L Pagano; N Pimpinelli; M Santucci; L Cerroni; C M Croce; F Facchetti; P P Piccaluga; S A Pileri
Journal:  Leukemia       Date:  2014-02-07       Impact factor: 11.528

6.  Exome sequencing reveals novel and recurrent mutations with clinical impact in blastic plasmacytoid dendritic cell neoplasm.

Authors:  J Menezes; F Acquadro; M Wiseman; G Gómez-López; R N Salgado; J G Talavera-Casañas; I Buño; J V Cervera; S Montes-Moreno; J M Hernández-Rivas; R Ayala; M J Calasanz; M J Larrayoz; L F Brichs; M Gonzalez-Vicent; D G Pisano; M A Piris; S Álvarez; J C Cigudosa
Journal:  Leukemia       Date:  2013-09-27       Impact factor: 11.528

7.  Twenty-one cases of blastic plasmacytoid dendritic cell neoplasm: focus on biallelic locus 9p21.3 deletion.

Authors:  Marco Lucioni; Francesca Novara; Giacomo Fiandrino; Roberta Riboni; Daniele Fanoni; Mariarosa Arra; Luigia Venegoni; Marta Nicola; Elena Dallera; Luca Arcaini; Francesco Onida; Pamela Vezzoli; Erica Travaglino; Emanuela Boveri; Orsetta Zuffardi; Marco Paulli; Emilio Berti
Journal:  Blood       Date:  2011-09-07       Impact factor: 22.113

8.  TCL1 expression in plasmacytoid dendritic cells (DC2s) and the related CD4+ CD56+ blastic tumors of skin.

Authors:  Marco Herling; Michael A Teitell; Rhine R Shen; L Jeffrey Medeiros; Dan Jones
Journal:  Blood       Date:  2003-02-06       Impact factor: 22.113

Review 9.  Blastic Plasmacytoid Dendritic Cell Neoplasm: From Origin of the Cell to Targeted Therapies.

Authors:  Kamel Laribi; Nathalie Denizon; Anne Besançon; Jonathan Farhi; Pierre Lemaire; Jeremy Sandrini; Catherine Truong; Habib Ghnaya; Alix Baugier de Materre
Journal:  Biol Blood Marrow Transplant       Date:  2016-03-26       Impact factor: 5.742

Review 10.  A cutaneous agranular CD2- CD4+ CD56+ "lymphoma": report of two cases and review of the literature.

Authors:  J Kameoka; R Ichinohasama; M Tanaka; I Miura; Y Tomiya; S Takahashi; M Yamada; I Ishikawa; I Kadowaki; O Sasaki; J Kimura; K Meguro; K Ooya; S Ito
Journal:  Am J Clin Pathol       Date:  1998-10       Impact factor: 2.493

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.